Embolism in sinoatrial disease

Area of Science:

• Cardiology
• Vascular Medicine
• Medical Device Therapy

Background:

• Permanent pacemaker implantation is a common treatment for cardiac arrhythmias.
• Sinoatrial disease and atrioventricular block are primary indications for pacemaker use.
• Systemic vascular events, including embolism, are potential complications of cardiac procedures.

Purpose of the Study:

• To investigate the incidence of systemic vascular events in patients treated with permanent pacemakers.
• To compare embolism rates among patients with different underlying cardiac conditions: sinoatrial disease with paroxysmal tachycardia, sinoatrial disease without tachycardia, and atrioventricular block.
• To evaluate the potential need for anticoagulant therapy in specific patient groups.

Main Methods:

• Retrospective study design.
• Analysis of consecutive patients treated with permanent pacemakers between 1965 and 1976.
• Categorization of patients into three groups based on cardiac condition: sinoatrial disease with paroxysmal tachycardia (Group A), sinoatrial disease without tachycardia (Group B), and atrioventricular block (Group C).
• Assessment of systemic vascular events compatible with embolism.

Main Results:

• Group A (sinoatrial disease with paroxysmal tachycardia) exhibited the highest incidence of embolism at 35%.
• Group B (sinoatrial disease without tachycardia) showed a 7% embolism rate.
• Group C (atrioventricular block) had a 10% embolism rate.
• Patient groups were comparable in age, comorbidities, and pacemaker therapy duration.

Conclusions:

• Patients with the brady-tachycardia syndrome (sinoatrial disease with paroxysmal tachycardia) face a significantly higher risk of embolic events post-pacemaker implantation.
• Anticoagulant therapy warrants consideration for patients diagnosed with the brady-tachycardia syndrome to mitigate embolism risk.
• Further evaluation of anticoagulant strategies is recommended for this high-risk patient population.